Suppr超能文献

心力衰竭管理的最佳效果 - 荟萃分析的综合评价,考察了减少心力衰竭再住院的干预措施的有效性。

Optimal effectiveness of heart failure management - an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure.

机构信息

Netherlands Heart Network, Veldhoven, The Netherlands.

Catharina Hospital, Eindhoven, The Netherlands.

出版信息

Heart Fail Rev. 2022 Sep;27(5):1683-1748. doi: 10.1007/s10741-021-10212-8. Epub 2022 Mar 3.

Abstract

Heart failure (HF) is a major health concern, which accounts for 1-2% of all hospital admissions. Nevertheless, there remains a knowledge gap concerning which interventions contribute to effective prevention of HF (re)hospitalization. Therefore, this umbrella review aims to systematically review meta-analyses that examined the effectiveness of interventions in reducing HF-related (re)hospitalization in HFrEF patients. An electronic literature search was performed in PubMed, Web of Science, PsycInfo, Cochrane Reviews, CINAHL, and Medline to identify eligible studies published in the English language in the past 10 years. Primarily, to synthesize the meta-analyzed data, a best-evidence synthesis was used in which meta-analyses were classified based on level of validity. Secondarily, all unique RCTS were extracted from the meta-analyses and examined. A total of 44 meta-analyses were included which encompassed 186 unique RCTs. Strong or moderate evidence suggested that catheter ablation, cardiac resynchronization therapy, cardiac rehabilitation, telemonitoring, and RAAS inhibitors could reduce (re)hospitalization. Additionally, limited evidence suggested that multidisciplinary clinic or self-management promotion programs, beta-blockers, statins, and mitral valve therapy could reduce HF hospitalization. No, or conflicting evidence was found for the effects of cell therapy or anticoagulation. This umbrella review highlights different levels of evidence regarding the effectiveness of several interventions in reducing HF-related (re)hospitalization in HFrEF patients. It could guide future guideline development in optimizing care pathways for heart failure patients.

摘要

心力衰竭(HF)是一个主要的健康问题,占所有住院患者的 1-2%。然而,关于哪些干预措施有助于有效预防 HF(再)住院,仍存在知识差距。因此,本综述旨在系统地综述分析了干预措施在减少射血分数降低的心力衰竭(HFrEF)患者 HF 相关(再)住院方面的有效性的荟萃分析。在 PubMed、Web of Science、PsycInfo、Cochrane Reviews、CINAHL 和 Medline 中进行了电子文献检索,以确定过去 10 年内以英文发表的合格研究。首先,为了综合荟萃分析数据,使用了最佳证据综合方法,根据有效性水平对荟萃分析进行了分类。其次,从荟萃分析中提取并检查了所有独特的 RCT。共纳入 44 项荟萃分析,涵盖 186 项独特的 RCT。有强有力或中等强度的证据表明,导管消融、心脏再同步治疗、心脏康复、远程监测和肾素-血管紧张素-醛固酮系统抑制剂可以减少(再)住院。此外,有限的证据表明,多学科诊所或自我管理促进计划、β受体阻滞剂、他汀类药物和二尖瓣治疗可以减少 HF 住院。对于细胞治疗或抗凝的效果,没有或存在矛盾的证据。本综述强调了关于几种干预措施在减少 HFrEF 患者 HF 相关(再)住院方面的有效性的不同证据水平。它可以为未来优化心力衰竭患者护理途径的指南制定提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd80/9388464/a7b662fa25c1/10741_2021_10212_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验